Baricitinib 2mg tablets
NHS hospitals in England used £15,883,689 of indicative cost of Baricitinib 2mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 1.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Baricitinib 2mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Baricitinib 2mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Nth Tees&Hartlepool Nhs Foundation Trust | £668,701 |
| Cumbria Partnership Nhs Foundation Trust | £648,418 |
| The Royal Wolverhampton Nhs Trust | £380,800 |
| Frimley Health Nhs Foundation Trust | £377,635 |
| Western Sussex Hospitals Nhs Found Trust | £361,696 |
| Oxford University Hospitals Nhs Ft | £351,512 |
| United Lincolnshire Hospitals Nhs Trust | £343,169 |
| Manchester University Nhs Ft | £334,825 |
| University Hpls Of Leicester Nhs Trust | £327,518 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £313,334 |
The primary-care picture
Baricitinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Baricitinib medicine page.